Neil Chatterji
Stock Analyst at B. Riley Securities
(0)
# 4027
Out of 5,270 analysts
24
Total ratings
28.57%
Success rate
-5.62%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ClearPoint Neuro | Maintains: Strong Buy | 15 20 | 13.53 | 47.82% | 2 | Jan 28, 2025 | |
OptimizeRx | Maintains: Buy | 17 13 | 4.88 | 166.39% | 3 | Dec 24, 2024 | |
Augmedix | Reinstates: Buy | 6 | n/a | n/a | 3 | Apr 3, 2024 | |
Establishment Labs H... | Maintains: Buy | 95 50 | 42.96 | 16.39% | 2 | Nov 9, 2023 | |
Silk Road Medical | Downgrades: Neutral | 54 14 | n/a | n/a | 3 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 | 1.92 | 290.62% | 1 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 18 | 13.65 | 31.87% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | 3.31 | 35.95% | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 4 | 0.94 | 272.34% | 3 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 1.96 | 180.61% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | 13.02 | 145.78% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 3.04 | 212.5% | 1 | Oct 4, 2022 |